Model Informed Drug Development Archives

Case Study

Certara & Dizal Partner to Fast-Track FDA Approval of Sunvozertinib for Lung Cancer

Certara’s support enabled fast-track FDA oncology approval 2025 for Sunvozertinib, a breakthrough NSCLC therapy targeting…

CertaraOctober 2, 2025

Conference

37th Annual Meeting of the Southern California Chapter Society of Toxicology (SCCSOT)

CertaraSeptember 22, 2025

Announcement

Certara Launches Libra™: AI-Powered Drug-Induced Liver Injury Prediction Tool

RADNOR, Pa. – September 17, 2025 – Certara, Inc. (Nasdaq: CERT), a global leader in…

CertaraSeptember 17, 2025

Guide

Top 10 Things to Know About ADNCA for Non-Compartmental Analysis

Learn how to transition from non-standard ADPC datasets to the CDISC ADNCA ADaM standard. Improve…

CertaraSeptember 11, 2025

Conference

Redefining Every Stage of Investment (RESI) Seed to Exit

–

CertaraSeptember 5, 2025

Conference

The Pharmacometrics Africa Conference 2025 (PMXAC-2025)

CertaraSeptember 4, 2025

Live Events

Certara Biotech Forum: Workshop on Developing Investor-Ready Strategies

– London, UK

CertaraSeptember 4, 2025

On-Demand Webinar

The Pursuit of Certainty: Integrated Evidence and the evolving drug development and reimbursement landscape

Watch leading experts from Pfizer, Merck, Amicus, and Certara discuss how Integrated Evidence can bridge…

CertaraSeptember 3, 2025

On-Demand Webinar

Designing a High-Value Drug Development Program: From Concept to First-in-Human (FIH)

Learn to design drug development programs for First-in-Human (FIH) success with biomarkers, PK/PD modeling, and…

CertaraAugust 29, 2025

On-Demand Webinar

Blueprint for Biotech Success: De-risking Early Development to Secure Long-Term Value

Discover strategies to cut risk, speed timelines, and boost investor confidence in early biotech development.

CertaraAugust 21, 2025

Model Informed Drug Development

Certara & Dizal Partner to Fast-Track FDA Approval of Sunvozertinib for Lung Cancer

37th Annual Meeting of the Southern California Chapter Society of Toxicology (SCCSOT)

Certara Launches Libra™: AI-Powered Drug-Induced Liver Injury Prediction Tool

Top 10 Things to Know About ADNCA for Non-Compartmental Analysis

Redefining Every Stage of Investment (RESI) Seed to Exit

The Pharmacometrics Africa Conference 2025 (PMXAC-2025)

Certara Biotech Forum: Workshop on Developing Investor-Ready Strategies

The Pursuit of Certainty: Integrated Evidence and the evolving drug development and reimbursement landscape

Designing a High-Value Drug Development Program: From Concept to First-in-Human (FIH)

Blueprint for Biotech Success: De-risking Early Development to Secure Long-Term Value

Newsletter sign up

Quick links

Solutions

Contact